about
Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic isletsThe actions of 5-, 12-, and 15-HETE on tracheobronchial smooth muscleFormation of hepoxilin A4, B4 and the corresponding trioxilins from 12(S)-hydroperoxy-5,8,10,14,17-icosapentaenoic acidEffects of steroids on renal NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in ovariectomized ratsInhibitors of metal catalyzed lipid peroxidation reactions inhibit mucus secretion and 15 HETE levels in canine trachea.Structure of the active site of prostaglandin synthase from studies of depsides: an alternate view.Effect of acetylsalicylic acid on blood glucose and glucose regulatory hormones in mild diabetes.Evidence for the mechanism by which garlic inhibits platelet aggregation.Biological half-life of prostacyclin and 6-oxo-PGF1 alpha levels in plasma of patients with colonic cancer.Prostaglandin binding to different cell types of human uterus: quantitative light microscope autoradiographic study.Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteers.Effect of alpha-fetoprotein on arachidonic acid metabolism in the preadipocyte cell line OB 17.Gastric effects of leukotrienes.Primary thrombocythaemia in childhood: symptomatic episodes and their relationship to thromboxane A2, 6-keto-PGE1 and 12-hydroxy-eicosatetraenoic acid production: a case report.Cardiovascular actions of dietary polyunsaturates and related mechanisms. A state-of-the-art-review.Biological activities of 6-keto-prostaglandin E1.Prostacyclin from the uterus and woman's cardiovascular advantage.Evidence for the involvement of sulfidopeptide leukotrienes in the pathogenesis of Pichinde virus infection in strain 13 guinea pigs.Intrapreoptic injection of the prostacyclin metabolite, 6-keto-PGE1, produces pyrexia in the cat.Hypothesis: on the similar prostaglandin mediation in the anti-hypertensive action of alpha- and beta- adrenoceptor antagonists; confusion of present system of receptor classification?Effects of gamma-linolenic acid, dihomo-gamma-linolenic acid and ethanol on cultured human mammary carcinoma cells.Thromboxane A2 (TXA2) formation by washed human platelets under the influence of low and high density lipoproteins from healthy donors.The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.Cardiovascular effects of high frequency ventilation--the possible involvement of thromboxane.Plasma prostaglandins: 6-keto-PGF1 alpha, TXB2 and PGE2 in juvenile-onset diabetes determined by high-pressure liquid chromatography and radio-immunoassay.Urinary 6-keto-PGF1 alpha level in patients with childhood leukemia/lymphoma; a possible indicator of vascular damage.Effect of indomethacin treatment on prostaglandin excretion and tissue phospholipid fatty acid composition in rats bearing mammotropic pituitary tumor, MtT-F4.Absence of myocardial protection with prostacyclin during cardiac arrest.Effects of salicylate and indomethacin in nonfebrile rats at different ambient temperatures.Regression of lymphosarcoma by treatment with acetylsalicylic acid in rats.Renal prostaglandin E2 and the renin-angiotensin system in hypertensive disorders in man.Adrenergic stimulation of prostacyclin production in the rat tail artery. II. The role of calcium.Desacetyl-1-nantradol: a selective prostaglandin antagonist.Studies on the possible involvement of singlet oxygen and superoxide anion radicals in the cyclo-oxygenase reaction.Effects of ascorbic acid deficiency on the in vitro biosynthesis of cyclooxygenase metabolites in guinea pig lungs.Changes in cyclooxygenase activity and prostaglandin profiles during monoamine metabolism in rat brain homogenates.Inhibition of cyclooxygenase production does not prevent arachidonate from increasing extravascular lung water and albumin in an isolated dog lung.The role of metabolic activation of analgesics and non-steroidal anti-inflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma.Low density lipoprotein (LDL) from male volunteers stimulated the thromboxane formation by human platelets.Prostaglandins and mutagenesis: modification of phenytoin induced genetic damage by prostaglandins in lymphocyte cultures.
P1433
Q28267652-4B3BF36D-5D59-4366-B29A-B61845F5616AQ28275921-1C0FB9B4-A86B-4EC8-966E-EFC39EF9118FQ28287367-5D31DC15-E8C6-40F5-9E60-0ED81294FBB0Q28771329-274D86FA-950E-42AB-904F-FB8F227A673DQ34166780-89B3BBB2-1F59-4F83-A569-CE3C125F1482Q34259939-65FA9B9B-1962-4F3F-AB4D-B184A8D1BA67Q34277041-FEA2CC8E-E547-43A6-8113-5A909E09D7EBQ34685365-16938CC3-BA58-447B-960A-603D121C09F8Q34689725-57F3B5DC-1681-45DF-9C5F-51CA4A15A96AQ36425180-D466D9EC-0646-43EA-B3D0-00E5FFFD1901Q36462698-F49931A6-3773-4A52-AE8A-C386F9859CEFQ38351604-668311DB-C247-4F74-8DC5-4BDBA99AA4A7Q39508822-792B8502-FE64-4C15-BBAE-A6AD5331376DQ39538893-6E6AF068-2695-4FDF-8E1D-D97DB610D90BQ39730789-28FC6EA5-44E9-40F8-AD72-7D70EA78F98CQ40080249-842B2685-A8AF-4C34-8A54-379A7A4826B7Q40334871-880A225A-8784-4674-B43B-E7436826E3B7Q40804831-47ABAEC7-DBAA-496E-91BE-C5FC64BDF0B6Q40806969-BA555A77-DB71-4077-9FAD-F508F32DA85AQ41360989-4A93F736-732C-4AD6-BCE6-4DBD20AF203BQ41363727-FE318236-3422-4B32-8E82-49EB8E85EF4FQ41381452-406A23A8-64BE-4DDF-9E80-694FCE7E6112Q41384747-476DE712-2C22-4F3D-A1FD-23ED050B82C7Q41385126-A2F2B165-11A2-4FDC-9B59-DFAA3AB1AB0FQ41444770-28936114-61B2-46C5-9C7E-619BC3F46985Q41445974-045338BF-6FA4-4A46-954F-E7D73D13BA17Q41451552-8C2C01E3-F40C-4781-A320-8D64DF4E13EBQ41451559-EDE5CC93-A729-40BC-85ED-4E0ACBB49CCEQ41483634-6360335E-3372-4DD4-BFCE-27D761A051F2Q41483851-24F3F4A1-F748-463A-A1DB-824B4013F982Q41486091-F95FAC69-A991-4C04-B852-9C3915CE739DQ41491077-E76128CB-8935-4393-81F1-6480A02E2433Q41536618-FE8BC220-6E09-4FA4-B973-5D176B1505BAQ41560782-DF25EECB-FA4A-4CA6-8948-0E7C7AB13595Q41571155-B2FCE80E-029A-4FFD-A764-347EAA162900Q41572213-A5AC5BBD-0152-4194-9FD1-8481F919658CQ41572789-2BAC888B-B6B9-461F-8721-EF1C2436FBD6Q41573164-AA6DC32F-5DD8-420E-AB2B-9C6221BBD145Q41583868-6255468A-FBAE-44C5-ACE2-A697EC086638Q41584796-46FBBB0E-9898-4405-99CB-FA9F97422449
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Churchill Livingstone
@nl
wissenschaftliche Fachzeitschrift
@de
name
Prostaglandins, leukotrienes, and medicine
@ast
Prostaglandins, leukotrienes, and medicine
@en
Prostaglandins, leukotrienes, and medicine
@es
Prostaglandins, leukotrienes, and medicine
@it
Prostaglandins, leukotrienes, and medicine
@nl
type
label
Prostaglandins, leukotrienes, and medicine
@ast
Prostaglandins, leukotrienes, and medicine
@en
Prostaglandins, leukotrienes, and medicine
@es
Prostaglandins, leukotrienes, and medicine
@it
Prostaglandins, leukotrienes, and medicine
@nl
altLabel
Prostaglandins Leukot Med
@en
prefLabel
Prostaglandins, leukotrienes, and medicine
@ast
Prostaglandins, leukotrienes, and medicine
@en
Prostaglandins, leukotrienes, and medicine
@es
Prostaglandins, leukotrienes, and medicine
@it
Prostaglandins, leukotrienes, and medicine
@nl
P3181
P1055
P1156
P1476
Prostaglandins, leukotrienes, and medicine
@en